Latam Cancer Connection
  1. Início

Programação

Webinar
19:00 - 20:20
Webinar

Can the landscape in cHL further improve? Upcoming of new paradigms

19:00 - 19:05
Welcome & Introductions
19:05 - 19:35
Can the landscape in cHL further improve? Upcoming new paradigms
19:35 - 20:10
DLBCL and MCL: the "old", the "new", and what's to come
20:10 - 20:20
Closing Remarks
Webinar
19:00 - 20:30
Webinar

Evolution of the Management of TNBC

19:00 - 19:05
Welcome and Introductions
19:05 - 19:20
Recent advances on the treatment of early TNBC
19:20 - 19:35
Key Surgical Considerations for Optimal Outcomes in Early TNBC
19:35 - 19:55
Early TNBC Clinical Case Discussion
19:55 - 20:10
Treatment Algorithm for Patients With Metastatic TNBC
20:10 - 20:25
Metastatic TNBC Clinical Case Discussion
20:25 - 20:30
Closing remarks
Webinar
19:00 - 21:15
Webinar

Advance and Challenges in GU Tumors

19:00 - 19:05
Welcome and Introductions
19:05 - 19:17
Current and future therapeutic options in NMIBC
19:17 - 19:29
Best strategies for advanced bladder cancer
19:29 - 19:41
Biomarkers in Urothelial carcinoma - current use and future perspectives
19:41 - 19:53
Discussion
20:10 - 20:22
Locally Advanced RCC: how to incorporate the latest adjuvant data into clinical practice
20:22 - 20:34
How do you treat oligometastatic Renal Cell Carcinoma
20:34 - 20:46
Management of Nonclear Cell Renal Cell Carcinoma
20:46 - 20:58
mRCC: Sequential therapies in the era of immunotherapy
20:58 - 21:10
Discussion
21:10 - 21:15
Closing
Webinar
19:00 - 21:00
Webinar

What´s New in Endometrial and Cervical Cancers?

19:00 - 19:05
Welcome and Introductions
19:05 - 19:20
Emerging Data and its Impact on First-line Treatment of Advanced or Recurrent Endometrial Cancer
19:20 - 19:30
Clinical case discussion
19:30 - 19:45
Treatment approaches on the advanced EC following prior systemic therapy (FPST)
19:45 - 19:55
Clinical case discussion
19:55 - 20:00
Q&A
20:00 - 20:05
Welcome and introductions
20:05 - 20:20
Treatment Landscape in Persistent, Recurrent or Metastatic Cervical Cancer
20:20 - 20:30
Clinical case discussion
20:30 - 20:40
What to expect on the near future for the treatment of the locally advanced disease?
20:40 - 20:50
Challenges in cervical cancer surgery
20:50 - 21:00
Q&A + closing
Webinar
19:00 - 21:20
Webinar

Cutaneous Melanoma in Early Stages: An MDT approach. State of the Art and Clinical implications

19:00 - 19:05
Welcome and Introductions
19:05 - 19:20
Topic #1 - Understanding the risk of disease recurrence to inform treatment decisions: An MDT approach
Node Negative disease:
- Low-risk node-negative disease (stage I and IIA)
- High-risk node-negative disease (stage IIB and IIC)
19:20 - 19:50
Discussion (roundtable)
19:50 - 20:05
Topic #2 - Understanding the risk of disease recurrence to inform treatment decisions: An MDT approach
Node Positive disease:
- Stage IIIA: is it low or high risk?
- High-risk node-positive disease (stage IIIB, IIIC, IIID)
- Macroscopic vs Microscopic disease: Any difference?
20:05 - 20:35
Discussion (roundtable)
20:35 - 20:50
Topic #3 - Recurrence after adjuvant therapy: An evolving treatment landscape
20:50 - 21:20
Discussion (roundtable)
Webinar
19:00 - 20:20
Webinar

Navigating MDT perspectives, challenges and opportunities in Early-Stage NSCLC treatment in Latin America

19:00 - 19:05
Welcome and Introduction
19:05 - 19:10
Early-stage NSCLC treatment: A journey in evolution
19:10 - 19:50
Multidisciplinary case discussion/round table: Navigating perspectives, challenges and opportunities in ES NSCLC treatment in Latin America (based on a clinical case of IO in adjuvant treatment)
- Surgical approaches in 2023
- Pathology perspective and the role of biomarkers in Early Stage disease
- Clinical Oncologist perspective
- Screening initiatives and best practices in Latin America
19:50 - 20:00
How the current data fits in clinical practice
20:00 - 20:15
Q&A
20:15 - 20:20
Closing remarks
Webinar
19:00 - 21:00
Webinar

New advances in GI Cancers

19:00 - 19:05
Opening
19:05 - 19:20
1st Module: Esophagogastric cancer. Updates in the management of advanced esophagogastric cancers
19:20 - 19:25
Q&A
19:25 - 19:40
Clinical Case and Discussion 
19:40 - 19:55
2nd Module: Biliary cancers. Updates in the management of advanced biliary cancers
19:55 - 20:00
Q&A
20:00 - 20:15
Clinical Case and Discussion
20:15 - 20:30
3rd Module: colorectal cancer. Updates in the management of metastatic colorectal cancer
20:30 - 20:35
Q&A
20:35 - 20:55
Clinical Case and Discussion 
20:55 - 21:00
Closing
Webinar
19:00 - 20:20
Webinar

Evolution of Biomarkers in Lung Cancer

19:00 - 19:05
Welcome
19:05 - 19:30
Biomarkers for immunotherapy: liquid biopsy under the spotlight
19:30 - 19:55
From patient selection to study design: how can we build upon the concept of MRD to improve immunotherapy outcomes?
19:55 - 20:15
Q&A
20:15 - 20:20
Closing